Crinetics Reviews CRN04777 Phase 1 Single-ascending Dose Results


September 15, 2021 at 4:30 pm ET

Crinetics management will discuss the preliminary findings from the single ascending dose cohorts from the Phase 1 clinical study of CRN04777 that were reported today.